May 26, 2021– Anne Webster knew last fall how bad things would get for many of her patients when the drug company Eli Lilly unilaterally pulled out of offering discounts through the 340B drug pricing program on medications dispensed at community pharmacies. As the nurse practitioner at the endocrinology clinic for UnityPoint Health Methodist in Peoria, Ill., she cares for many … [Read more...]
New Federal 340B Order Is Major Step Toward Restoring Drug Discounts
May 19, 2021– The Health Resources & Services Administration (HRSA) has taken decisive action to put a stop to the actions of six drug companies that are denying 340B drug pricing program discounts for medications dispensed at community pharmacies. The action could lead to the end of a nearly year-long dispute pitting for-profit pharmaceutical companies against nonprofit … [Read more...]
More States Acting To Protect 340B Safety-Net Hospitals
May 12, 2021– Faced with increasing threats from some pharmaceutical benefit managers (PBMs) and drug companies, supporters of the 340B drug pricing program have turned to state governments for protection and are finding increasing support in the form of new protective laws thanks to the work of 340B advocates in the states. To date, 11 states have enacted important … [Read more...]
Americans Pay Far More for Drugs Than Other Countries
May 7, 2021– Americans are charged at least two to four times more for 20 major brand-name drugs, according to a new report to Congress. The Government Accountability Office (GAO) looked at the retail prices charged for brand-name, single-source drugs in the U.S. and compared them with those charged in Australia, Canada, and France. The researchers were able to adjust U.S. … [Read more...]
Faces of 340B: Meeting the Mission of a Healthier Community
April 29, 2021 – At MetroHealth in Cleveland, the health providers and the staff who support them work as one to meet the health system’s mission of “leading the way to a healthier you and a healthier community.” One of the key elements that helps turn these words into action is the 340B drug pricing program. MetroHealth is a system with four hospitals, more than 20 health … [Read more...]
Undoing Medicare 340B Cuts Would Not Cost Patients or Taxpayers Anything
April 23, 2021– Billions of dollars in Medicare payment cuts to hospitals participating in the 340B drug pricing program have harmed the health care safety net since they first went into effect more than three years ago. 340B hospitals and their supporters are asking the Biden administration and the 117th Congress to reverse those cuts and restore equity to Medicare Part B drug … [Read more...]
Research Highlights the Toll of Drug Maker Attacks on 340B, Shows How Hospitals Use Their Savings to Care for Patients
March 23, 2021– Newly released research demonstrates how patients benefit from the 340B drug pricing program in the form of expanded access and improved health outcomes. But there is growing evidence that the actions of six drug companies to cut off 340B discounts for certain drugs is sapping needed resources during the continued COVID-19 pandemic. 340B Health’s annual … [Read more...]